Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 2/14/2017
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / 2||UN / IM|
Administered by: Other Purchased by: Other
Symptoms: Abdominal pain, Diarrhoea, Dizziness, Dyskinesia, Dyspnoea, Dysuria, Headache, Infection, Muscular weakness, Nausea, Palpitations, Exercise tolerance decreased, Cognitive disorder, Tilt table test normal
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: No other medications
Current Illness: Human papilloma virus Immunisation
Diagnostic Lab Data: Examinations or lab samples: The tilt table test shows that the patient does not fulfill the criteria for Postural Orthostatic Tachycardia Syndrome.
CDC 'Split Type': WAES1608DNK009252
Write-up:Information has been received from Sanofi Pasteur MSD (SPM) (MFR control number DK-1577272925-2016008229) on 17-AUG-2016. Case received from a physician via health authority on 15-AUG-2016 under reference number DK-DKMA-WBS-0004235. A 15-year-old female adolescent patient received GARDASIL, batch number Not available, Dose 1 via intramuscular route on 08-OCT-2008, GARDASIL, batch number Not available, Dose 2 via intramuscular route on 10-DEC-2008, GARDASIL, batch number Not available, Dose 3 via intramuscular route on 15-APR-2009. The patient experienced recurrent infection, headache, dizziness, palpitation, nausea, abdominal pain, diarrhea, voiding difficulty, shortness of breath, cognitive disorder involuntary muscle movement, weakness of legs/weakness of arms and exercise tolerance decreased on an unknown date. The patient stated that she experienced the first symptom recurrent infection 1 month after her 3rd vaccination. The other symptoms followed. Before her vaccinations, the patient did tennis, fitness, horse-back riding in total 9 hours a week. The tilt table test showed that the patient did not fulfill the criteria Postural Orthostatic Tachycardia Syndrome. Other vaccinations or medications unknown. The patient''s outcome was reported as not recovered/not resolved for headache, dizziness, palpitation, nausea, abdominal pain, diarrhea, voiding difficulty, shortness of breath, cognitive disorder, involuntary muscle movement, and weakness of legs/weakness of arms. The patient''s outcome was reported as unknown for recurrent infection and exercise tolerance decreased.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166